Found: 5
Select item for more details and to access through your institution.
The GP2 peptide: A HER2/ neu-based breast cancer vaccine.
- Published in:
- Journal of Surgical Oncology, 2012, v. 105, n. 5, p. 452, doi. 10.1002/jso.21723
- By:
- Publication type:
- Article
Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 6, p. 2960, doi. 10.1245/s10434-021-09667-8
- By:
- Publication type:
- Article
Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 3, p. 1466, doi. 10.1245/s10434-020-08973-x
- By:
- Publication type:
- Article
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 391, doi. 10.1007/s10549-020-05638-x
- By:
- Publication type:
- Article
Chemoprevention in familial adenomatous polyposis: past, present and future.
- Published in:
- Familial Cancer, 2021, v. 20, n. 1, p. 23, doi. 10.1007/s10689-020-00189-y
- By:
- Publication type:
- Article